← Back to Search

Dietary Intervention for Healthy Habits and Diet

N/A

Recruiting

Led By Tim Spector, PhD

Research Sponsored by Zoe Global Limited

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Must not have

Have had a heart attack (myocardial infarction), stroke/transient ischemic attack (TIA), or major surgery in the last two months

Timeline

Screening 3 weeks

Treatment Varies

Follow Up time frame: 12 months: baseline, daily (0 to 4 weeks), monthly (5 to 52 weeks)

Awards & highlights

No Placebo-Only Group

Summary

This trial will help to refine machine learning models that predict individual responses to foods, in order to advance precision nutrition science and individualized dietary advice.

Who is the study for?

The trial is for adults who are part of the ZOE testing program, have a BMI of at least 16.5 kg/m2, and live in the continental US (excluding New York) or UK. They must be able to follow the study protocol and give informed consent. Those with chronic conditions should consult their doctor before joining.

What is being tested?

This study tests how different foods affect individuals by using machine learning models to predict responses to diet. Participants will undergo controlled dietary interventions and record their meals during a free-living period to assess various factors' impact on post-meal responses.

What are the potential side effects?

Since this is a dietary intervention trial focusing on normal food consumption patterns, no specific side effects are expected beyond typical food-related reactions such as allergies or intolerances that participants may already be aware of.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I have not had a heart attack, stroke/TIA, or major surgery in the last two months.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ time frame: 12 months: baseline, weekly (0 to 4 weeks), monthly (5 to 52 weeks)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~time frame: 12 months: baseline, weekly (0 to 4 weeks), monthly (5 to 52 weeks)

This trial's timeline: 3 weeks for screening, Varies for treatment, and time frame: 12 months: baseline, weekly (0 to 4 weeks), monthly (5 to 52 weeks) for reporting.